Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Edgewise Therapeutics Inc | EWTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 20.89 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 20.89 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 5.12 - 21.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 20.89 | USD |
Edgewise Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.95B | 93.11M | - | 0 | -100.16M | -1.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Edgewise Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EWTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 19.06 | 21.60 | 18.5301 | 20.18 | 751,309 | 1.83 | 9.60% |
| 1 Month | 15.91 | 21.60 | 14.90 | 17.65 | 601,747 | 4.98 | 31.30% |
| 3 Months | 18.22 | 21.60 | 14.90 | 17.22 | 733,934 | 2.67 | 14.65% |
| 6 Months | 6.27 | 21.60 | 5.12 | 14.15 | 811,414 | 14.62 | 233.17% |
| 1 Year | 9.74 | 21.60 | 5.12 | 12.85 | 499,995 | 11.15 | 114.48% |
| 3 Years | 29.22 | 29.98 | 5.12 | 13.01 | 320,422 | -8.33 | -28.51% |
| 5 Years | 27.00 | 40.49 | 5.12 | 13.45 | 315,964 | -6.11 | -22.63% |
Edgewise Therapeutics Description
| Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. |
